Blog Archives | Page 3 of 17

Connecting Genetic Drivers to Functional Proteomics: IsoPlexis Presents Data at SITC 2021

IsoPlexis2022-05-12T16:06:28-04:00

Connecting Genetic Drivers to Functional Proteomics: IsoPlexis Presents Data at SITC 2021IsoPlexis2022-05-12T16:06:28-04:00

eBook: Understanding Immune Cell Function in Cancer

IsoPlexis2022-05-12T16:06:29-04:00

eBook: Understanding Immune Cell Function in CancerIsoPlexis2022-05-12T16:06:29-04:00

Webinar Now Available – Sharpening a Double-Edged Sword: Bispecific CAR-T Cancer Therapies

IsoPlexis2022-05-12T16:06:30-04:00

Webinar Now Available – Sharpening a Double-Edged Sword: Bispecific CAR-T Cancer TherapiesIsoPlexis2022-05-12T16:06:30-04:00

Expert Panel Discussion: Advances in Cell and Immunotherapies in Treating Cancer

IsoPlexis2022-05-12T16:06:32-04:00

Expert Panel Discussion: Advances in Cell and Immunotherapies in Treating CancerIsoPlexis2022-05-12T16:06:32-04:00

Published in Blood Advances: IsoPlexis’ Single-Cell Biology Reveals Functional Biomarker Predictive of Improved Outcomes in AML

IsoPlexis2022-05-12T16:06:33-04:00

Published in Blood Advances: IsoPlexis’ Single-Cell Biology Reveals Functional Biomarker Predictive of Improved Outcomes in AMLIsoPlexis2022-05-12T16:06:33-04:00

Single-Cell Functional Proteomics Reveals Insights into Optimization of Radiation and Immunotherapy

IsoPlexis2022-05-12T16:06:35-04:00

Single-Cell Functional Proteomics Reveals Insights into Optimization of Radiation and ImmunotherapyIsoPlexis2022-05-12T16:06:35-04:00

Published in Blood: Isoplexis’ Single-Cell Proteomics Provides Insight into Mechanism of Action for Venetoclax and Azacytidine in Acute Myeloid Leukemia Treatment

IsoPlexis2022-05-12T16:06:36-04:00

Published in Blood: Isoplexis’ Single-Cell Proteomics Provides Insight into Mechanism of Action for Venetoclax and Azacytidine in Acute Myeloid Leukemia TreatmentIsoPlexis2022-05-12T16:06:36-04:00

Single-Cell Functional Proteomics Discovers a Potential Target for Enhancing NK Cell-Based Cancer Immunotherapy

IsoPlexis2022-05-12T16:06:38-04:00

Single-Cell Functional Proteomics Discovers a Potential Target for Enhancing NK Cell-Based Cancer ImmunotherapyIsoPlexis2022-05-12T16:06:38-04:00

Published in Nature Medicine: Utilizing IsoPlexis’ Single-Cell Proteomics and Product Quality Metrics in a Phase I Trial of TIL treatment for Metastatic Lung Cancer

IsoPlexis2022-05-12T16:06:39-04:00

Published in Nature Medicine: Utilizing IsoPlexis’ Single-Cell Proteomics and Product Quality Metrics in a Phase I Trial of TIL treatment for Metastatic Lung CancerIsoPlexis2022-05-12T16:06:39-04:00

Single-Cell Functional Biomarkers for Each Stage of the Cell Therapy Development Pipeline

IsoPlexis2022-05-12T16:06:41-04:00

Single-Cell Functional Biomarkers for Each Stage of the Cell Therapy Development PipelineIsoPlexis2022-05-12T16:06:41-04:00